Khosla Impact

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Partner and Investor

Peter Buckland

COO, Partner, and Managing Director

Brian Byun

Operating Partner

Catherine Casuga

Operating Partner

Jonathan Chu

Partner and Investor

Ardy Daie

Operating Partner

Ece Erdagoz Wyrick

Principal and Investor

Kanu Gulati

Partner

Judy Huang

Operating Partner

Jun Jeon MD

Principal

Samir Kaul

Founding Partner and Managing Director

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Nicholas Moryl

Associate

Keith Rabois

Managing Director

Arash Rebek

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Jai Sajnani

Partner and Investor

Jai Sajnani

Partner

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner and Investor

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner and Investor

Adina Tecklu

Partner and Investor

David Weiden

Managing Director

Reze Wong

Partner

Kanupriya Gulati Ph.D

Partner and Investor

Adam Coates

Operating Partner

Past deals in Mental Health

Marble Health

Seed Round in 2024
Marble Health provides access to personalized therapy to help teens in their mental health journey. Marble Health provides prompt and affordable care for middle and high school students experiencing common mental health issues such as anxiety, depression, and trauma. They ensure that all teens and their families can access treatment using their existing insurance coverage, including both commercial and Medicaid plans.

Limbic

Series A in 2024
Limbic is a London-based company founded in 2017 that specializes in developing innovative solutions for mental healthcare. The company creates an AI-enabled platform and software development kit (SDK) that measures heart rates through wearable devices, such as the Apple Watch, to assess users' emotional states. By leveraging machine learning, Limbic aims to enhance psychological therapy by providing insights into patients' mental health conditions. Additionally, the company offers medical devices that facilitate referrals and clinical assessments, thereby supporting mental health professionals in delivering effective therapies. Limbic is committed to addressing the growing mental health crisis by providing scalable solutions that improve the well-being of individuals.

Flow Neuroscience

Series A in 2021
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Ellipsis Health

Series A in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

Yes Health

Series A in 2020
Yes Health Inc. is a company that specializes in developing mobile application software focused on nutrition, fitness, and diabetes prevention. Established in 2015 and based in Mill Valley, California, Yes Health provides a program that delivers personalized advice and encouragement to support a healthy lifestyle. The program features a team of physicians, health coaches, and engineers who collaborate to create an engaging, cost-effective solution aimed at preventing the onset of diabetes and managing symptoms for those already diagnosed. By emphasizing the development of lasting healthy habits, Yes Health empowers individuals to take control of their health in an enjoyable manner, ultimately striving to combat diabetes.

Ginger

Series C in 2019
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.

Flow Neuroscience

Venture Round in 2019
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Flow Neuroscience

Seed Round in 2018
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Ellipsis Health

Seed Round in 2017
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing innovative analytics solutions that integrate patient speech and clinical data to assess mental health and well-being. By utilizing artificial intelligence, Ellipsis Health aims to enhance behavioral health outcomes through the analysis of natural conversation. The company has created a platform that generates clinical-grade assessments of anxiety and depression severity, as well as sub-clinical evaluations of stress levels. This technology enables healthcare providers to continuously screen their patient populations, offering a cost-effective method to identify conditions such as depression and ensure patients receive timely support.

Vida Health

Series B in 2016
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company provides a comprehensive platform that integrates mental and physical health treatment, utilizing a clinically validated approach that combines artificial intelligence with personalized support from human coaches and licensed therapists. Through its application, users have access to video sessions, messaging, and tailored digital content designed to help them prevent, manage, and reverse chronic conditions such as diabetes and hypertension, alongside related mental health issues like stress and anxiety. Founded in 2012 and originally known as Via Health, Inc., Vida Health aims to treat the whole health of individuals by tackling the root causes of their conditions.

Thync

Series B in 2016
Thync, Inc. is a technology company based in Los Gatos, California, founded in 2011. The company specializes in developing wearable devices that leverage neurosignaling to facilitate transitions between different mental states, such as energy, calm, and focus. Drawing on expertise in neurobiology and neuroscience, Thync creates bioelectronic products aimed at enhancing mental well-being and addressing various consumer needs. Their innovative technology enables users to boost energy levels and improve mental clarity by directly activating specific nerves and neurons through neurostimulation patches. Thync's focus on the intersection of neuroscience and consumer electronics positions it as a pioneer in the field of wearable mental health technology.

Ginger

Series B in 2014
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.

Vida Health

Series A in 2014
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company provides a comprehensive platform that integrates mental and physical health treatment, utilizing a clinically validated approach that combines artificial intelligence with personalized support from human coaches and licensed therapists. Through its application, users have access to video sessions, messaging, and tailored digital content designed to help them prevent, manage, and reverse chronic conditions such as diabetes and hypertension, alongside related mental health issues like stress and anxiety. Founded in 2012 and originally known as Via Health, Inc., Vida Health aims to treat the whole health of individuals by tackling the root causes of their conditions.

Thync

Series A in 2014
Thync, Inc. is a technology company based in Los Gatos, California, founded in 2011. The company specializes in developing wearable devices that leverage neurosignaling to facilitate transitions between different mental states, such as energy, calm, and focus. Drawing on expertise in neurobiology and neuroscience, Thync creates bioelectronic products aimed at enhancing mental well-being and addressing various consumer needs. Their innovative technology enables users to boost energy levels and improve mental clarity by directly activating specific nerves and neurons through neurostimulation patches. Thync's focus on the intersection of neuroscience and consumer electronics positions it as a pioneer in the field of wearable mental health technology.

Ginger

Series A in 2012
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.